Drug Target Review: Fixing failed drugs - AI solutions for toxicity in drug discovery Part 2

Cambridge Independent: Ignota Labs CSO Jordan Lane becomes an enterprise fellow at Clare Hall

Drug Target Review: Fixing failed drugs - AI solutions for toxicity in drug discovery Part 2

Drug Target Review: Fixing failed drugs - AI solutions for toxicity in drug discovery Part 1

Business Weekly: Honour for CSO maintains upward trajectory for Ignota Labs

Dr Jordan Lane appointed as Industry and Enterprise Fellow at Clare Hall, University of Cambridge

Generative AI for Drug Discovery

Biopharma Dealmakers: Turning failing drugs into hope for patients